pd-1 therapy with eribulin for triple negative mbc
Published 7 years ago • 177 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
6:10
pd-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer
-
5:25
investigational pd-l1–targeted immunotherapy safe for patients with triple-negative breast cancer
-
20:43
investigational pd-l1–targeted immunotherapy safe for patients with triple-negative breast cancer
-
1:08
a study investigating pembrolizumab in combination with eribulin in tnbc
-
6:06
combination of eribulin and capecitabine provides clinical benefit for women with mbc
-
3:00
eribulin’s role in triple-negative breast cancer
-
8:05
keynote-522: immune therapy and chemotherapy in patients with early triple negative breast cancer
-
20:37
the role of chemotherapy in the treatment of metastatic breast cancer patients
-
2:31
gut microbiome signatures correlate with os in pts receiving eribulin /- pembro for hr mbc
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc
-
1:02
ebcc 8: triple negative advanced breast cancer treatment with parp inhibitors
-
2:38
nivolumab and ipilimumab with tumour-infiltrating lymphocytes to treat triple-negative breast ca...
-
3:40
treatment with eribulin in metastatic breast cancer
-
12:45
keynote-355: first-line pembrolizumab plus chemotherapy for metastatic triple-negative breast ca...
-
3:26
dr. sara tolaney on eribulin plus pembrolizumab for metastatic triple-negative breast cancer
-
6:51
treatment with eribulin mesylate in metastatic breast cancer
-
5:49
efficacy and gene expression results from eribulin solti1007 neoadjuvant study
-
1:42
checkpoint inhibitors for triple-negative breast cancer
-
28:03
triple negative breast cancer - o'regan